ID

12769

Descripción

Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00385996

Link

https://clinicaltrials.gov/show/NCT00385996

Palabras clave

Versiones (1)
  1. 21/12/15 21/12/15 -
Subido en

21 de diciembre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Carcinoma, Non-small Cell Lung NCT00385996

Inglés

Eligibility Carcinoma, Non-small Cell Lung NCT00385996

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
biopsy proven stage i/ii non-small cell lung cancer who are candidates for surgical resection
Descripción

Non-Small Cell Lung Carcinoma; Excision

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007131
UMLS CUI [2]
C0728940
ambulatory and capable of all self-care but may be unable to carry out any work activities.
Descripción

self-care; ambulatory

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3639376
UMLS CUI [2]
C1550332
preoperative and postoperative high resolution ct scans done at nyph-weill cornell medical center for purposes of volumetric measurements.
Descripción

ct scans preoperative postoperative

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040405
UMLS CUI [1,2]
C0445204
UMLS CUI [1,3]
C0205903
acceptable cardiac, breathing, kidney, liver, and bone marrow functions.
Descripción

Cardiac function normal

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0232164
UMLS CUI [1,2]
C0205307
18 years and older.
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
women of child-bearing potential must be taking adequate contraceptive precautions prior to study entry and for the duration of study participation. a negative serum or urine pregnancy test is required within 7-10 days of tarceva® administration. men and premenopausal women of child bearing potential will follow an approved, medically accepted birth control regimen or agree to abstain from heterosexual intercourse while taking study drug and for 30 days following the last dose of study drug.
Descripción

pregnancy; Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0549206
UMLS CUI [2]
C0700589
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
cannot be on any other anti-cancer treatment during this study.
Descripción

Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
prior treatment with any egfr inhibitor.
Descripción

Epidermal growth factor receptor inhibitor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1443775
patients who had prior treatment with chemotherapy or radiation for this disease.
Descripción

chemotherapy; radiotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0034619
other active cancers.
Descripción

active cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
tumors with a mixed histology of small cell and non-small cell carcinoma as well as patients with pulmonary carcinoid tumors.
Descripción

comorbidity Lung Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0024121
gastro-intestinal abnormalities, including active peptic ulcer or inflammatory bowel disease.
Descripción

comorbidity Gastrointestinal Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0017178
hypersensitivity to compounds similar in chemical composition to tarceva®.
Descripción

hypersensitivity tarceva

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1135136
active infection or serious underlying medical conditions which would impair protocol treatment.
Descripción

Compliance behavior limited comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
Volver a la parte superior de la página

Similar models

Eligibility Carcinoma, Non-small Cell Lung NCT00385996

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma; Excision
Item
biopsy proven stage i/ii non-small cell lung cancer who are candidates for surgical resection
boolean
C0007131 (UMLS CUI [1])
C0728940 (UMLS CUI [2])
self-care; ambulatory
Item
ambulatory and capable of all self-care but may be unable to carry out any work activities.
boolean
C3639376 (UMLS CUI [1])
C1550332 (UMLS CUI [2])
ct scans preoperative postoperative
Item
preoperative and postoperative high resolution ct scans done at nyph-weill cornell medical center for purposes of volumetric measurements.
boolean
C0040405 (UMLS CUI [1,1])
C0445204 (UMLS CUI [1,2])
C0205903 (UMLS CUI [1,3])
Cardiac function normal
Item
acceptable cardiac, breathing, kidney, liver, and bone marrow functions.
boolean
C0232164 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
age
Item
18 years and older.
boolean
C0001779 (UMLS CUI [1])
pregnancy; Contraceptive methods
Item
women of child-bearing potential must be taking adequate contraceptive precautions prior to study entry and for the duration of study participation. a negative serum or urine pregnancy test is required within 7-10 days of tarceva® administration. men and premenopausal women of child bearing potential will follow an approved, medically accepted birth control regimen or agree to abstain from heterosexual intercourse while taking study drug and for 30 days following the last dose of study drug.
boolean
C0549206 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status
Item
cannot be on any other anti-cancer treatment during this study.
boolean
C2348568 (UMLS CUI [1])
Epidermal growth factor receptor inhibitor
Item
prior treatment with any egfr inhibitor.
boolean
C1443775 (UMLS CUI [1])
chemotherapy; radiotherapy
Item
patients who had prior treatment with chemotherapy or radiation for this disease.
boolean
C0392920 (UMLS CUI [1])
C0034619 (UMLS CUI [2])
active cancer
Item
other active cancers.
boolean
C0006826 (UMLS CUI [1])
comorbidity Lung Neoplasms
Item
tumors with a mixed histology of small cell and non-small cell carcinoma as well as patients with pulmonary carcinoid tumors.
boolean
C0009488 (UMLS CUI [1,1])
C0024121 (UMLS CUI [1,2])
comorbidity Gastrointestinal Diseases
Item
gastro-intestinal abnormalities, including active peptic ulcer or inflammatory bowel disease.
boolean
C0009488 (UMLS CUI [1,1])
C0017178 (UMLS CUI [1,2])
hypersensitivity tarceva
Item
hypersensitivity to compounds similar in chemical composition to tarceva®.
boolean
C0020517 (UMLS CUI [1,1])
C1135136 (UMLS CUI [1,2])
Compliance behavior limited comorbidity
Item
active infection or serious underlying medical conditions which would impair protocol treatment.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial